ArticleThe Korean journal of internal medicine2020

Fimasartan, an angiotensin II receptor antagonist, ameliorates an in vivo zebrafish model of heart failure.

Hailian Quan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.